Good response of cadonilimab (PD-1/CTLA-4 bi-specific antibody) to patients with advanced lung adenocarcinoma after immunotherapy resistance: A case report.
作者信息
An Erjing, Lu Junfeng, Chen Lijuan
机构信息
Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
出版信息
Asian J Surg. 2024 Jul;47(7):3348-3349. doi: 10.1016/j.asjsur.2024.03.189. Epub 2024 Apr 11.
PMID:38609824
Abstract
摘要
Zotero 插件